BIOCLAVIS LIMITEDActive
Key figures
Like most small UK companies, BIOCLAVIS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2024
| 2019/20 | 2020/21 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 685,051 | 981,596 | 870,097 | 697,474 | 685,216 |
| Total assets | 2,053,896 | — | — | — | — |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 598,641 | 1,597,869 | 1,542,978 | 1,174,490 | 1,075,408 |
| Average number of employees | 17 | 23 | 27 | 13 | 11 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The principal activity of the Company continued to be that of research and experimental development on biotechnology.
As described in the company's latest filed accounts.
Summary: BIOCLAVIS LIMITED
Company
BIOCLAVIS LIMITED is a private limited company registered with Companies House under company number SC575642. It was incorporated on 6 Sep 2017. Its status is active. The registered office is in Clydebank (G81). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts (filleted). Net assets were £1,075,408, down 8.4% on the previous year. Cash at bank and in hand was £685,216. The company had an average of 11 employees. Figures are available for 5 financial years (2019/20–2024).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 13 Sep 2027.